Seasonal Variation in Metabolic Syndrome Components: How Much Do They Influence the Diagnosis of Metabolic Syndrome?

Current Cardiovascular Risk Reports

Volumn 5, Issue 1, 2011, Pages 29-37

  Carlström, Mattias ^a,b  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Adipokine; Adipose tissue; Age; ATP III, cardiovascular disease; Cholesterol; DASH; Diabetes; Diet; Dyslipidemia; Gender; Gene polymorphism; High density lipoprotein; Hypertension; IDF; Insulin resistance; Low density lipoprotein; NCEP; Nitrate; Nitric oxide; Obesity; Oxidative stress; Vitamin D

Indexed keywords

ANTIOXIDANT; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRIC OXIDE SYNTHASE; PARATHYROID HORMONE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; REACTIVE OXYGEN METABOLITE; TRIACYLGLYCEROL; VITAMIN D RECEPTOR;

ANTIOXIDANT ACTIVITY; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CLIMATE CHANGE; CLINICAL TRIAL (TOPIC); DIET; DISORDERS OF LIPID METABOLISM; DYSLIPIDEMIA; FOOD INTAKE; GENETIC VARIABILITY; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INFLAMMATION; LIFESTYLE MODIFICATION; LIPID PEROXIDATION; METABOLIC SYNDROME X; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OXIDATIVE STRESS; PHYSICAL ACTIVITY; PREVALENCE; REVIEW; RISK FACTOR; VITAMIN D DEFICIENCY;

EID: 84873524997     PISSN: 19329520     EISSN: 19329563     Source Type: Journal    
DOI: 10.1007/s12170-010-0139-z     Document Type: Review

References (58)

1. Despres JP, Lemieux I: Abdominal obesity and metabolic syndrome. Nature 2006, 444: 881-887.
2. Eckel RH, Grundy SM, Zimmet PZ: The metabolic syndrome. Lancet 2005, 365: 1415-1428.
3. •• Maury E, Brichard SM: Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol 2010, 314: 1-16. This review discusses the link between adipokine dysregulation and metabolic syndrome. It also highlights molecular mechanisms involved in adipose inflammation.
4. Stern MP, Williams K, Gonzalez-Villalpando C, et al.: Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? Diabetes Care 2004, 27: 2676-2681.
5. Gu D, Reynolds K, Wu X, et al.: Prevalence of the metabolic syndrome and overweight among adults in China. Lancet 2005, 365: 1398-1405.
6. Eckel RH, Alberti KG, Grundy SM, Zimmet PZ: The metabolic syndrome. Lancet 2010, 375: 181-183.
7. Wilcox CS: Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension? Am J Physiol Regul Integr Comp Physiol 2005, 289: R913-935.
8. Partonen T: Metabolic syndrome follows a seasonal cycle. Hypertens Res 2010, 33: 534.
9. Alberti KG, Zimmet P, Shaw J: The metabolic syndrome-a new worldwide definition. Lancet 2005, 366: 1059-1062.
10. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001, 285: 2486-2497.
11. Definition and the diagnostic standard for metabolic syndrome-Committee to Evaluate Diagnostic Standards for Metabolic Syndrome [Japanese]. Nippon Naika Gakkai Zasshi 2005, 94: 794-809.
12. Fujita T: The metabolic syndrome in Japan. Nat Clin Pract Cardiovasc Med 2008, 5(Suppl 1): S15-18.
13. Kimm H, Lee SW, Lee HS, et al.: Associations between lipid measures and metabolic syndrome, insulin resistance and adiponectin. Usefulness of lipid ratios in Korean men and women. Circ J 2010, 74: 931-937.
14. Minami J, Kawano Y, Ishimitsu T, et al.: Seasonal variations in office, home and 24 h ambulatory blood pressure in patients with essential hypertension. J Hypertens 1996, 14: 1421-1425.
15. Ockene IS, Chiriboga DE, Stanek EJ 3rd, et al.: Seasonal variation in serum cholesterol levels: treatment implications and possible mechanisms. Arch Intern Med 2004, 164: 863-870.
16. •• Kamezaki F, Sonoda S, Tomotsune Y, et al.: Seasonal variation in metabolic syndrome prevalence. Hypertens Res 2010, 33: 568-572. This article demonstrates that seasonal variation in metabolic syndrome components influences diagnosis of the syndrome. Also, the prevalence was influenced by what definition of the metabolic syndrome that was used.
17. Carlstrom M: Seasonal variation may affect clinical diagnosis of metabolic syndrome. Hypertens Res 2010, 33: 531-533.
18. Cheng TO: Seasonal variation in serum cholesterol levels may be another explanation for seasonal variation in acute myocardial infarction. Int J Cardiol 2005, 104: 101.
19. •• Kamezaki F, Sonoda S, Tomotsune Y, et al.: Seasonal variation in serum lipid levels in Japanese workers. J Atheroscler Thromb 2010, 17: 638-643. This article demonstrates that there is a seasonal variation in serum lipid levels and the prevalence of hypercholesterolemia in Japanese workers.
20. Rosenthal T: Seasonal variations in blood pressure. Am J Geriatr Cardiol 2004, 13: 267-272.
21. Cozzolino M, Ketteler M, Zehnder D: The vitamin D system: a crosstalk between the heart and kidney. Eur J Heart Fail 2010 (in press).
22. Ford ES, Ajani UA, McGuire LC, Liu S: Concentrations of serum vitamin D and the metabolic syndrome among U. S. adults. Diabetes Care 2005, 28: 1228-1230.
23. Chowdhury TA, Boucher BJ, Hitman GA: Vitamin D and type 2 diabetes: Is there a link? Prim Care Diabetes 2009, 3: 115-116.
24. •• Lee DM, Rutter MK, O'Neill TW, et al.: Vitamin D, parathyroid hormone and the metabolic syndrome in middle-aged and older European men. Eur J Endocrinol 2009, 161: 947-954. This article demonstrates an inverse relationship between vitamin D levels and metabolic components, including waist circumference, systolic blood pressure, triglycerides, and glucose levels.
25. • Oplander C, Volkmar CM, Paunel-Gorgulu A, et al.: Whole body UVA irradiation lowers systemic blood pressure by release of nitric oxide from intracutaneous photolabile nitric oxide derivates. Circ Res 2009, 105: 1031-1040. This study shows that moderate UVA irradiation of skin lowers blood pressure in humans. The effects were attributed to UVA-induced release of NO from cutaneous NO-related species.
26. Feelisch M, Kolb-Bachofen V, Liu D, et al.: Is sunlight good for our heart? Eur Heart J 2010, 31: 1041-1045.
27. Rintamaki R, Grimaldi S, Englund A, et al.: Seasonal changes in mood and behavior are linked to metabolic syndrome. PLoS One 2008, 3: e1482.
28. • Grimaldi S, Englund A, Partonen T, et al.: Experienced poor lighting contributes to the seasonal fluctuations in weight and appetite that relate to the metabolic syndrome. J Environ Public Health 2009, 2009: 165013. This article show that seasonal variations in mood and behavior have a metabolic factor composed of weight and appetite that is linked with sunlight exposure. Lighting conditions may serve as an intervention to prevent the metabolic syndrome.
29. • Ramachandran A, Ma RC, Snehalatha C: Diabetes in Asia. Lancet 2010, 375: 408-418. This article discusses the alarming increase in diabetes and cardiovascular disease in Asian populations. It discusses underlying mechanisms and stresses the importance of preventive lifestyle modifications.
30. Li G, Zhang P, Wang J, et al.: The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet 2008, 371: 1783-1789.
31. Joshipura KJ, Hu FB, Manson JE, et al.: The effect of fruit and vegetable intake on risk for coronary heart disease. Ann Intern Med 2001, 134: 1106-1114.
32. Sobko T, Marcus C, Govoni M, Kamiya S: Dietary nitrate in Japanese traditional foods lowers diastolic blood pressure in healthy volunteers. Nitric Oxide 2010, 22: 136-140.
33. • Liese AD, Nichols M, Sun X, et al.: Adherence to the DASH Diet is inversely associated with incidence of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes Care 2009, 32: 1434-1436. This article discusses the alarming increase in diabetes and cardiovascular disease in Asian populations. It discusses underlying mechanisms and stresses the importance of preventive lifestyle modifications.
34. Appel LJ, Moore TJ, Obarzanek E, et al.: A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 1997, 336: 1117-1124.
35. •• Lundberg JO, Gladwin MT, Ahluwalia A, et al.: Nitrate and nitrite in biology, nutrition and therapeutics. Nat Chem Biol 2009, 5: 865-869. Fruits and vegetables have considerable high amounts of inorganic nitrate, and accumulating data show beneficial effects of inorganic nitrate in the cardiovascular system.
36. Monti LD, Barlassina C, Citterio L, et al.: Endothelial nitric oxide synthase polymorphisms are associated with type 2 diabetes and the insulin resistance syndrome. Diabetes 2003, 52: 1270-1275.
37. Bryan NS, Fernandez BO, Bauer SM, et al.: Nitrite is a signaling molecule and regulator of gene expression in mammalian tissues. Nat Chem Biol 2005, 1: 290-297.
38. Cook S, Hugli O, Egli M, et al.: Clustering of cardiovascular risk factors mimicking the human metabolic syndrome X in eNOS null mice. Swiss Med Wkly 2003, 133: 360-363.
39. • Huang PL: eNOS, metabolic syndrome and cardiovascular disease. Trends Endocrinol Metab 2009, 20: 295-302. This review summarizes evidence that reduction in endothelium-derived NO serves as a key link between metabolic syndrome and increased cardiovascular risk.
40. Nisoli E, Clementi E, Paolucci C, et al.: Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science 2003, 299: 896-899.
41. Duplain H, Burcelin R, Sartori C, et al.: Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase. Circulation 2001, 104: 342-345.
42. • Carlstrom M, Larsen FJ, Nystrom T, et al.: Dietary inorganic nitrate reverses features of metabolic syndrome in endothelial nitric oxide synthase-deficient mice. Proc Natl Acad Sci U S A 2010, 107: 17716-17720. This study shows that inorganic nitrate, in a dose resembling a diet rich in fruits and vegetables, can partly compensate for disturbances in endogenous NO generation from eNOS and reverse features of the metabolic syndrome.
43. •• Roberts CK, Sindhu KK: Oxidative stress and metabolic syndrome. Life Sci 2009, 84: 705-712. This review discusses the role of oxidative stress in metabolic syndrome and cardiovascular disease. It also highlights the importance of lifestyle modification in ameliorating oxidative stress in metabolic syndrome.
44. Fujita K, Nishizawa H, Funahashi T, et al.: Systemic oxidative stress is associated with visceral fat accumulation and the metabolic syndrome. Circ J 2006, 70: 1437-1442.
45. Furukawa S, Fujita T, Shimabukuro M, et al.: Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004, 114: 1752-1761.
46. • Holvoet P: Relations between metabolic syndrome, oxidative stress and inflammation and cardiovascular disease. Verh K Acad Geneeskd Belg 2008, 70: 193-219. The authors have shown that the metabolic syndrome is associated with higher levels of circulating oxidized LDL and increased risk for cardiovascular events. This review discusses how oxidative stress modulates inflammation, metabolic syndrome, and its outcome.
47. • Devaraj S, Leonard S, Traber MG, Jialal I: Gamma-tocopherol supplementation alone and in combination with alpha-tocopherol alters biomarkers of oxidative stress and inflammation in subjects with metabolic syndrome. Free Radic Biol Med 2008, 44: 1203-1208. This article demonstrates a therapeutical role of antioxidant tocopherols in preventing metabolic syndrome.
48. Garcia-Alonso M, Minihane AM, Rimbach G, et al.: Red wine anthocyanins are rapidly absorbed in humans and affect monocyte chemoattractant protein 1 levels and antioxidant capacity of plasma. J Nutr Biochem 2009, 20: 521-529.
49. • Basu A, Sanchez K, Leyva MJ, et al.: Green tea supplementation affects body weight, lipids, and lipid peroxidation in obese subjects with metabolic syndrome. J Am Coll Nutr 2010, 29: 31-40. This article demonstrates that antioxidant properties of green tea affect lipoproteins, with therapeutical effects in patients with metabolic syndrome.
50. • Kaya A, Uzunhasan I, Baskurt M, et al.: Oxidative status and lipid profile in metabolic syndrome: gender differences. Metab Syndr Relat Disord 2010, 8: 53-58. There are conflicting data regarding gender differences in metabolic syndrome and its components. This study shows that women have better antioxidant status than men, which may explain the lower prevalence of cardiovascular events.
51. • Kochan TI, Eseva TV: Seasonal dynamics of clinically significant metabolic parameters in northern residents of different age. Bull Exp Biol Med 2009, 147: 757-759. This study in northern residents shows that seasonal variation in metabolic parameters was higher in older individuals than in young people.
52. Groop L: Genetics of the metabolic syndrome. Br J Nutr 2000, 83(Suppl 1): S39-48.
53. Yesilaltay A, Kocher O, Rigotti A, Krieger M: Regulation of SR-BI-mediated high-density lipoprotein metabolism by the tissue-specific adaptor protein PDZK1. Curr Opin Lipidol 2005, 16: 147-152.
54. • Junyent M, Arnett DK, Tsai MY, et al.: Genetic variants at the PDZ-interacting domain of the scavenger receptor class B type I interact with diet to influence the risk of metabolic syndrome in obese men and women. J Nutr 2009, 139: 842-848. This article shows that PDZK1 genetic variants influence the risk of metabolic syndrome in obese men and women. This gene is involved in lipoprotein metabolism and impaired function of LDL-C and VLDL-C particles.
55. Lindholm E, Melander O, Almgren P, et al.: Polymorphism in the MHC2TA gene is associated with features of the metabolic syndrome and cardiovascular mortality. PLoS One 2006, 1: e64.
56. Phillips CM, Goumidi L, Bertrais S, et al.: Leptin receptor polymorphisms interact with polyunsaturated fatty acids to augment risk of insulin resistance and metabolic syndrome in adults. J Nutr 2010, 140: 238-244.
57. Phillips CM, Goumidi L, Bertrais S, et al.: Additive effect of polymorphisms in the IL-6, LTA, and TNF-{alpha} genes and plasma fatty acid level modulate risk for the metabolic syndrome and its components. J Clin Endocrinol Metab 2010, 95: 1386-1394.
58. Englund A, Kovanen L, Saarikoski ST, et al.: NPAS2 and PER2 are linked to risk factors of the metabolic syndrome. J Circadian Rhythms 2009, 7: 5.